Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -924.78x is 548% below its 1-year average of -142.75x, near the low end of its 1-year range (-924.78x–-6.28x).
338.31% below its 12-month average of -210.99x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): -300.11x.
INTEREST COVERAGE RATIO
-924.78x
INTEREST COVERAGE RATIO AVG TTM
-210.99x
INTEREST COVERAGE RATIO AVG 3Y
-142.75x
INTEREST COVERAGE RATIO AVG 5Y
-142.75x
INTEREST COVERAGE RATIO AVG 10Y
-108.11x
INTEREST COVERAGE RATIO AVG 15Y
-91.11x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-338.31%
CURRENT VS 3Y AVG
-547.83%
CURRENT VS 5Y AVG
-547.83%
CURRENT VS 10Y AVG
-755.38%
CURRENT VS 15Y AVG
-914.99%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 387 covered companies
CURRENT VS SECTOR MEDIAN
-18432.67%
vs the sector median at left
InMed Pharmaceuticals Inc.
Market Cap
$7.31M
Interest Coverage Ratio
-924.78x
TTM Avg
-210.99x
3Y Avg
-142.75x
5Y Avg
-142.75x
Market Cap
$7.28M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.20M
Interest Coverage Ratio
-185.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.09M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.94M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.83M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.31M | -924.78x | -210.99x | -142.75x | -142.75x |
| Longeveron Inc. (LGVN)vs › | $7.42M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.22M | -11.95x | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.28M | -496.55x | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.20M | -185.05x | N/A | N/A | N/A |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.09M | N/A | N/A | N/A | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.94M | N/A | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | -1049.68x | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.78M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.76M | N/A | N/A | N/A | N/A |
Interest Coverage
-924.8x
Debt/Equity
0.00
Current Ratio
1.37
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -300.11x |
| 2025-06-30 | -121.87x |
| 2024-12-31 | -6.28x |
| 2020-12-31 | -4.20x |
| 2011-06-30 | -23.11x |
| 2011-03-31 | -616.75x |
| 2010-12-31 | -8.80x |
| 2010-09-30 | -12.54x |
| 2010-06-30 | -6.70x |
| 2010-03-31 | -17.22x |
| 2009-06-30 | -22.91x |
| 2009-03-31 | -34.96x |
| 2008-12-31 | -67.85x |
| 2008-09-30 | 206.38x |
